Cyprumed is a dedicated drug delivery company based in Innsbruck, Austria. Backed by our team of industry experts, we make therapeutic peptides orally bioavailable.
Our innovative tablet formulation technology enhances bioavailability while being scalable, cost-efficient, and easy to manufacture.
Cyprumed’s proprietary platform is well suitable for macrocyclic peptides, miniproteins and acylated peptides.
We collaborate with leading pharmaceutical companies to develop regulatory-compliant tablet formulations for their active pharmaceutical ingredients based on approved excipients.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Innsbruck, Tyrol
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.cyprumed.net
- Keywords
- Oral peptide drug delivery, GLP-1 oral formulation, macrocylcic peptides, miniproteins, Oral BCS IV drug delivery, Scalable & cost-efficient manufacturing, Shelf-stable oral peptide products, Intestinal peptide delivery platform, Gastric peptide delivery platform, Tablet formulation technology.
- HQ
- Innsbruck, Tyrol
Cyprumed Gmbh Questions
Cyprumed Gmbh's website is http://www.cyprumed.net
Cyprumed Gmbh's LinkedIn profile is https://at.linkedin.com/company/cyprumed
Cyprumed Gmbh has
3 employees.
View email and phone details for 3
employees at Cyprumed Gmbh.
Cyprumed Gmbh's industry is
Pharmaceutical Manufacturing
Cyprumed Gmbh's top competitors are
Msd,
Oak Hill Bio,
Shape Capital Partners,
Standortagentur Tirol,
Astrazeneca,
Palatin Technologies,
Irbm,
Eit Health Austria,
Health Hub Tirol,
Anyo Labs.
Cyprumed Gmbh's categories are Pharmaceutical Manufacturing
Cyprumed Gmbh's founding year is 2015
